Purpose of the KONFIDENT Study
The purpose of the KONFIDENT Study is to understand the effects of an investigational oral medication called KVD900 in adolescents and adults (12 years of age and older) with HAE type I or type II. Doctors are studying 2 different doses to see which one may be best as a safe on-demand treatment for HAE attacks.
